|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,444.00 JPY | +1.76% |
|
+3.00% | -2.37% |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.11B | 2.17B | 2.5B | 2.77B | 2.9B | |||||
Total Revenues | 2.11B | 2.17B | 2.5B | 2.77B | 2.9B | |||||
Cost of Goods Sold, Total | 501M | 496M | 720M | 926M | 1.04B | |||||
Gross Profit | 1.61B | 1.67B | 1.78B | 1.84B | 1.86B | |||||
Selling General & Admin Expenses, Total | 688M | 656M | 716M | 746M | 811M | |||||
Depreciation & Amortization - (IS) | 16M | 16M | 15M | 36M | 2M | |||||
Other Operating Expenses, Total | 704M | 672M | 731M | 782M | 813M | |||||
Operating Income | 908M | 999M | 1.05B | 1.06B | 1.05B | |||||
Interest And Investment Income | - | - | - | 2M | 10M | |||||
Net Interest Expenses | - | - | - | 2M | 10M | |||||
Other Non Operating Income (Expenses) | - | - | 3M | - | 2M | |||||
EBT, Excl. Unusual Items | 908M | 999M | 1.05B | 1.06B | 1.06B | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | - | - | - | - | 6M | |||||
EBT, Incl. Unusual Items | 908M | 999M | 1.05B | 1.06B | 1.07B | |||||
Income Tax Expense | 304M | 329M | 340M | 332M | 352M | |||||
Earnings From Continuing Operations | 604M | 670M | 713M | 728M | 716M | |||||
Net Income to Company | 604M | 670M | 713M | 728M | 716M | |||||
Net Income - (IS) | 604M | 670M | 713M | 728M | 716M | |||||
Net Income to Common Incl Extra Items | 604M | 670M | 713M | 728M | 716M | |||||
Net Income to Common Excl. Extra Items | 604M | 670M | 713M | 728M | 716M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 80.78 | 89.51 | 95.23 | 97.23 | 95.63 | |||||
Basic EPS - Continuing Operations | 80.78 | 89.51 | 95.23 | 97.23 | 95.63 | |||||
Basic Weighted Average Shares Outstanding | 7.48M | 7.49M | 7.49M | 7.49M | 7.49M | |||||
Net EPS - Diluted | 80.72 | 89.51 | 95.23 | 97.23 | 95.63 | |||||
Diluted EPS - Continuing Operations | 80.72 | 89.51 | 95.23 | 97.23 | 95.63 | |||||
Diluted Weighted Average Shares Outstanding | 7.48M | 7.49M | 7.49M | 7.49M | 7.49M | |||||
Normalized Basic EPS | 75.9 | 83.41 | 87.9 | 88.48 | 88.65 | |||||
Normalized Diluted EPS | 75.84 | 83.41 | 87.9 | 88.48 | 88.65 | |||||
Payout Ratio | 25.83 | 25.67 | 26.23 | 29.81 | 34.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.09B | 1.22B | 1.33B | 1.43B | 1.46B | |||||
EBITA | 908M | 999M | 1.05B | 1.06B | 1.05B | |||||
EBIT | 908M | 999M | 1.05B | 1.06B | 1.05B | |||||
Effective Tax Rate - (Ratio) | 33.48 | 32.93 | 32.29 | 31.32 | 32.96 | |||||
Normalized Net Income | 568M | 624M | 658M | 662M | 664M | |||||
Non-Cash Pension Expense | -6M | -8M | -2M | -2M | 1M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 48M | 71M | 93M | 87M | 106M | |||||
Selling and Marketing Expenses | 48M | 71M | 93M | 87M | 106M | |||||
General and Administrative Expenses | 31M | 27M | 34M | 28M | 29M | |||||
Research And Development Expense From Footnotes | 20M | - | - | - | - |
- Stock Market
- Stocks
- 3969 Stock
- Financials ATLED CORP.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















